Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2003
05/22/2003US20030095987 Recombinant parainfluenza virus expression system and vaccines
05/22/2003US20030095979 Xn-PeptideL-Xm, where X is Gly, Ala, Val, Leu, Ile, Pro, Phe, Tyr, Trp, Cys, Met, Glu or Asp; and PeptideL is a potentially immunogenic fragment; and a polycationic material; vaccines
05/22/2003US20030095976 Methods to improve immunogenicity of antigens and specificity of antibodies
05/22/2003US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists.
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2466632A1 Injectable depot compositions and uses thereof
05/22/2003CA2466519A1 Method for treating autoimmune diseases
05/22/2003CA2466440A1 Cannabinoid receptor ligands
05/22/2003CA2466355A1 Neurotransmitter balance chemotherapy
05/22/2003CA2466264A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003CA2465893A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464419A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same
05/21/2003EP1312670A1 Method of extensive culture of antigen-specific cytotoxic t cells
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1312373A1 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
05/21/2003EP1312372A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1312359A2 Use for 1,3-propanediol compounds
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1312259A1 Type iii allergic inflammation model animal
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311658A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
05/21/2003EP1311543A1 T cell receptor v beta-d beta-j beta sequence and methods for its detection
05/21/2003EP1311542A2 Peptide selection method
05/21/2003EP1311541A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5)
05/21/2003EP1311536A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311522A1 New immunoeffector compounds
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311502A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
05/21/2003EP1311498A1 Diamino phenothiazine derivatives and composition comprising same
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1311288A1 Immunostimulatory nucleic acids for inducing a th2 immune response
05/21/2003EP1311269A2 Method of using diketopiperazines and composition containing them
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1311236A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations
05/21/2003EP1200066B1 Aqueous nasal formulation
05/21/2003EP1129096B1 Crf receptor antagonists and methods relating thereto
05/21/2003EP1009732B1 1-amino-alkylcyclohexane nmda receptor antagonists
05/21/2003EP0988042A4 A combination therapy for hiv infections
05/21/2003EP0923581B1 4-substituted beta-carbolines as immunomodulators
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0706394B1 Use of a compostion comprising histamine phosphate for the manufacture of a medicament for the topical treatment of epithelial inflammation or lesions
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419563A Peptide derivative
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1418703A Nano particle feeding system for oral use
05/21/2003CN1418652A Traditional Chinese medicine granule contg. Radix Astragalus seu Hedysari, Herba Dendrobii, Frutus Crataegi; and its prepn. process
05/21/2003CN1418643A Method for bathing with traditional Chinese medicine for anti human immunodeficiency virus and improving immunity
05/21/2003CN1418630A Solution agent of antiallergi medicine contg. levocetirizine
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1109049C Adjuvent composition containing cyclodextrin and vaccine having same
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109032C Compounds analogous to thalidomide from class comprising pipeidine-2,6-diones
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof
05/21/2003CN1109016C Synthetic polyunsaturated fatty acid analogues
05/21/2003CN1108967C Metering valve
05/21/2003CN1108818C Activated immune globulin
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/21/2003CN1108807C Chinese herbs extract and preparation method and use thereof
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566538 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
05/20/2003US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/20/2003US6566498 Proteins for use in the treatment of thrombosis and tumor metastisis
05/20/2003US6566405 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics
05/20/2003US6566394 Useful as anti-inflammatory agents and immunosuppressive agents
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566352 Administering alpha -hydroxy-2-methylene-19-nor-pregnacalciferol compound for therapy of psoriasis
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6565897 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
05/20/2003US6565859 Galenical formulations
1 ... 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 ... 1172